Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-70,800
Closed -$2.46M 4642
2020
Q4
$2.46M Hold
70,800
﹤0.01% 2082
2020
Q3
$1.23M Hold
70,800
﹤0.01% 2510
2020
Q2
$1.16M Sell
70,800
-11,600
-14% -$176K ﹤0.01% 2624
2020
Q1
$747K Buy
82,400
+57,700
+234% +$1.16M ﹤0.01% 3255
2019
Q4
$525K Sell
24,700
-19,200
-44% -$426K ﹤0.01% 4261
2019
Q3
$1.01M Buy
43,900
+28,800
+191% +$657K ﹤0.01% 3660
2019
Q2
$366K Buy
15,100
+8,400
+125% +$173K ﹤0.01% 4601
2019
Q1
$87K Buy
6,700
+3,100
+86% +$54.3K ﹤0.01% 5469
2018
Q4
$54K Buy
3,600
+700
+24% +$18.1K ﹤0.01% 5427
2018
Q3
$114K Hold
2,900
﹤0.01% 5434
2018
Q2
$143K Sell
2,900
-3,400
-54% -$193K ﹤0.01% 5005
2018
Q1
$376K Sell
6,300
-2,410
-28% -$161K ﹤0.01% 4240
2017
Q4
$685K Sell
8,710
-8,000
-48% -$645K ﹤0.01% 3501
2017
Q3
$1.4M Buy
16,710
+12,434
+291% +$882K ﹤0.01% 2681
2017
Q2
$280K Sell
4,276
-7,010
-62% -$477K ﹤0.01% 4071
2017
Q1
$820K Buy
11,286
+5,595
+98% +$368K ﹤0.01% 2910
2016
Q4
$333K Buy
+5,691
New +$300K ﹤0.01% 3742

Other funds holding ADNT

Barclays's ADNT Position: Q2 2026 in Review

Barclays reduced its Adient (ADNT) stake by 23% in Q2 2026, selling an estimated $712K and leaving 111,161 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2325.

Barclays first reported a position in ADNT in Q4 2016 and has held it in 39 quarters since. The position peaked at $11.4M in Q4 2023. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Barclays held 111,161 shares of Adient worth $2.04M as of Q2 2026.
  • Barclays sold 33,298 Adient shares in Q2 2026, an estimated $712K.
  • Adient made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2325 holding.
  • Barclays first reported a position in Adient in Q4 2016 and has held it in 39 quarters since.
  • Barclays's Adient position peaked at $11.4M in Q4 2023.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.